Current stage 3 trials for multiple sclerosis medications may address several unmet needs in the patient population.
Mina Baghzouz, PharmD
Advertisement
Articles by Mina Baghzouz, PharmD
Advertisement
Latest Updated Articles
- Late-Stage Pipeline Review for Multiple Sclerosis Treatments
Published: February 14th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
3
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
4
When to Call, When to Counsel: Statin Drug Interactions
5
